Esperion Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
17 Nov 2025	Form 3: Harlow John B. Jr., Chief Commercial Officer No securities owned
02 Jul 2025	Form 3: Thompson John Craig, Director No securities owned
02 Apr 2025	Form 3: Hoffman Robert E., Director No securities owned
16 Nov 2022	Form 3: Halladay Benjamin, Chief Financial Officer Holds 19,771 shares of Common Stock
01 Jun 2022	Form 3: Carroll J Martin, Director No securities owned
28 Apr 2022	Form 3: Rocamboli Stephen, Director No securities owned
09 Mar 2022	Form 3: Warren Eric, Chief Commercial Officer Holds 11,207 shares of Common Stock
04 Jan 2022	Form 3: Looker Benjamin, General Counsel No securities owned
01 Nov 2021	Form 3: Fischer Seth H. Z., Director No securities owned
08 Jul 2021	Form 3: Foody Joanne M., Chief Medical Officer No securities owned
15 Dec 2020	Form 3: Koenig Sheldon L., Chief Operating Officer No securities owned
18 Mar 2020	Form 3: Fuhrman Alan, Director Holds 654 shares of Common Stock
28 Feb 2020	Form 3: Hall Ashley, Chief Development Officer Holds 10,000 shares of Common Stock
31 May 2019	Form 3: Woody Tracy M, Director No securities owned
21 Dec 2018	Form 3: Glickman Mark A, Chief Commercial Officer Holds 20,000 shares of Common Stock
30 Oct 2018	Form 3: Braslyn Ltd., 10% owner and 4 others Holds 1,401,000 shares of Common Stock
29 May 2018	Form 3: Shepard Jay, Director No securities owned
10 May 2018	Form 3: Biotech Target N V, 10% owner and 1 other Holds 2,822,964 shares of Common Stock
23 Feb 2018	Form 3: Berkowitz Jeffrey, Director No securities owned
14 Dec 2017	Form 3: Bartram Richard, Chief Financial Officer Holds 1,200 shares of Common Stock

Comments